Back
Ascendis Pharma AS Stock Price Chart

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
ASND
Ascendis Pharma AS
Last Price:
$152.81
Seasonality Move:
-9.72%
7 Day Trial
ALL ACCESS PASS
$
7

Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight selling pressure.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 150.68 | Buy |
20-day SMA: | 150.15 | Buy |
50-day SMA: | 138.19 | Buy |
200-day SMA: | 134.26 | Buy |
8-day EMA: | 150.9 | Buy |
20-day EMA: | 147.65 | Buy |
50-day EMA: | 141.23 | Buy |
200-day EMA: | 134.31 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.25 | Buy |
Relative Strength Index (14 RSI): | 57.66 | Buy |
Chaikin Money Flow: | -63248 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (132.1 - 157.28) | Buy |
Bollinger Bands (100): | (124.48 - 143.94) | Buy |
Ascendis Pharma AS Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 152.98 while ASND 8-day simple moving average is 150.68, which is a Buy signal.
-
The stock price of ASND is 152.98 while Ascendis Pharma AS 20-day SMA is 150.15, which makes it a Buy.
-
Ascendis Pharma AS 50-day simple moving average is 138.19 while ASND share price is 152.98, making it a Buy technically.
-
ASND stock price is 152.98 and Ascendis Pharma AS 200-day simple moving average is 134.26, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
46
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a SellThe current Ascendis Pharma AS [ASND] share price is $152.98. The Score for ASND is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
9.2B
Price in USD:
152.98
Share Volume:
405.8K
Ascendis Pharma AS 52-Week Range
52-Week High:
158.00
52-Week Low:
111.09
Sell
46
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?The Ascendis Pharma AS stock price is 152.98 USD today.
-
Will ASND stock go up or go down?Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Ascendis Pharma AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 152.98 while ASND 8-day exponential moving average is 150.90, which is a Buy signal.
-
The stock price of ASND is 152.98 while Ascendis Pharma AS 20-day EMA is 147.65, which makes it a Buy.
-
Ascendis Pharma AS 50-day exponential moving average is 141.23 while ASND share price is 152.98, making it a Buy technically.
-
ASND stock price is 152.98 and Ascendis Pharma AS 200-day simple moving average is 134.31, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.17 per share, an increase this year of $3.03 per share, and an increase next year of $5.43 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
-
ASND Moving Average Covergence Divergence (MACD) indicator is 4.25, suggesting Ascendis Pharma AS is a Buy
-
Ascendis Pharma AS Relative Strength Index (RSI) is 57.66, which suggest Ascendis Pharma AS is overbought
-
The Bollinger Bands (25) for Ascendis Pharma AS is (132.1 - 157.28), which suggest Ascendis Pharma AS is a Buy
-
The Bollinger Bands (100) for Ascendis Pharma AS is (124.48 - 143.94), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.